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THE pSYCHiATRiC BOTTLEnECK
Psychiatric conditions that include depression, schizophrenia, and dementia contribute most sig-
nificantly to overall disability adjusted life years (DALYs), surpassing both cardiovascular disease 
and cancer (1, 2). Therefore, timely and accurate diagnosis and treatment are crucial in psychiatric 
disorders, for which the development of specific biomarkers would be of particular importance. 
Despite advances in the field of Psychiatry with more comprehensive classification and description 
of diagnostic criteria, a pathophysiologically oriented classification of psychiatric disorders based 
on neurobiological basis remains elusive. The human brain with its complex integrative functions 
of cognition, emotional regulation, and executive function is the most challenging object of study 
in human science. Mental illness occurs as a result of these brain dysfunctions, but they often do 
not lead to distinct pathologic lesions or tissue damage. Instead, they contribute to complications 
in synaptic relay, synaptic plasticity, and neural circuit function, in addition to influence by exter-
nal psychosocial factors. Thus, standard imaging methodologies, such as computed tomography 
(CT) and magnetic resonance imaging (MRI), would not be adequate to delineate the underlying 
abnormality contributing to the dysfunction. Our inherent lack of understanding of the mind–brain 
interface and the difficulty in characterizing mental illness further makes the practice of Psychiatry 
all the more daunting.
Being the only medical specialty without any objective diagnostic tool or marker, the current 
diagnostic process in Psychiatry is regretfully based on patients’ reports of symptoms, observed 
behavior, and disease progression, which can introduce subjectivity and bias. Many clinical symp-
toms are also common to various psychiatric disorders, such as depressive symptoms in unipolar 
depression, bipolar disorder, schizoaffective disorder, etc., thus making it challenging to diagnose 
complex cases accurately within a limited time frame. This is illustrated by studies in the United States 
that revealed approximately 70% of bipolar patients were initially misdiagnosed due to polymorphic 
clinical symptoms (3, 4). It is also not uncommon to find different psychiatrists having deferring 
opinions about a case due to their unique experiences and training. Therefore, there is an urgent 
need for specific, objective biomarker-based assessments to guide diagnosis and treatment. The use 
of such biomarkers could assist clinicians in establishing differential diagnosis, which may improve 
specific individualized treatment.
EMERGEnCE OF OpTiCAL TOpOGRApHY in An ERA OF 
FUnCTiOnAL BRAin iMAGinG
Functional brain imaging modalities, such as functional magnetic brain imaging (fMRI), positron 
emission tomography (PET), and single-photon emission computed tomography (SPECT), have 
2Ho et al. Optical Topography in Psychiatry
Frontiers in Psychiatry | www.frontiersin.org April 2016 | Volume 7 | Article 74
been increasingly used over the years in research to reveal struc-
tural and functional abnormalities in psychiatric disorders. This 
is partly due to the increased awareness of psychiatric disorders 
as having a neurobiological basis and the emergence of more 
neuroimaging tools. Nevertheless, they have difficulty translating 
to bedside clinical use for diagnostic and treatment purposes 
due to the large machineries involved, high cost incurred, and 
that the assessment has to be done in very controlled artificial 
environments (lying still for extended periods), which potentially 
contributes to inconsistent and imprecise findings of functional 
brain alterations.
The introduction of optical topography that uses near-infrared 
spectroscopy (NIRS) have led to a paradigm shift in the investiga-
tion of healthy and abnormal brain functional processes within 
the cerebral cortex over the last two decades. Its mechanism of 
action, which is similar to fMRI, exploits the different absorp-
tion spectra of oxygenated and deoxygenated hemoglobin in the 
near infrared region, to measure changes in the concentrations 
of oxygenated and deoxygenated hemoglobin, thereby reflect-
ing regional cerebral blood flow (5). Despite having limitations 
in spatial resolution and depth of penetration (unable to assess 
subcortical areas, which often play a significant role in psychiatric 
disorders), with confounding influence by systemic factors such 
as autonomic, neuroendocrine, and vascular functions, and 
anatomical factors, such as scalp–cortex distance, frontal sinus 
volume, and skin integrity (6), optical topography has several 
unique advantages that makes its application attractive for neu-
roscience and particularly psychiatric research. The device being 
small and portable enables assessment in the natural environment 
during real-life social interaction and allowing bodily movement 
due to its relative insensitivity to movement artifacts. This is 
particularly suitable for psychiatric patients who have phobia of 
enclosed environments and motor restlessness, and they usually 
prefer hassle-free procedures. It can also be applied on patients 
who are more severely ill who will benefit from quick measure-
ment at the bedside, such as those in the intensive care unit. It 
also has good temporal resolution (less than 1 s) that is useful for 
characterizing the time course of brain activity. Furthermore, it 
can be combined with other brain imaging techniques, such as 
electroencephalogram (EEG), SPECT, and fMRI, to enhance the 
holistic understanding of functional characteristics underpinning 
psychiatric disorders. This device that is relatively cheap and safe 
can be used in clinical settings for measuring brain activity of not 
only adults but also children and the elderly. The fast processing 
of data also allows for studying of large samples.
niRS AppLiCATiOn in pSYCHiATRiC 
DiSORDERS
Over the two decades, the optical topography community has 
shifted from basic validation studies in healthy controls, to psy-
chological studies focusing on visual, auditory, motor, language, 
and cognitive paradigms, and to the more recent phenomenologi-
cal characterization of psychiatric disorders. At least 115 original 
articles have used NIRS to investigate psychiatric research ques-
tions by 2014 (7), and this number is expected to exponentially 
increase with the realization of versatile applicability of the 
technology and the increase in types of NIRS devices available in 
the market (Hitachi ETG-400, NIRScout, Artinis, etc.).
In affective disorders, frontal lobe abnormalities, particularly 
the decrease in bilateral frontotemporal oxygenation, have been 
found in unipolar depression using the verbal fluency test (VFT) 
(8). Some of these studies further noted frontotemporal activa-
tion to be positively correlated with adaptive coping (9) while 
negatively correlated with symptom severity (8). In schizophre-
nia, there were reduced hemodynamic responses in the prefrontal 
cortex of patients compared to controls (10), and was partly found 
to be affected by clinical characteristics such as age of onset of 
symptoms, medication effects, and psychopathological symptom 
scores, thereby inferring association between prefrontal cortex 
function and specific symptom dimensions (7). In personality 
disorders, patients with borderline personality disorders were 
found to have a reduced slope of task-related oxygenation increase 
in the left prefrontal area compared to controls when viewing sad 
pictures, and this had a negative association with clinical symp-
toms of interpersonal difficulties and fear of abandonment (11). 
Even in the areas of substance abuse, Schecklmann et al. revealed 
a reduced extent of cerebral oxygenation in the frontotemporal 
areas of detoxified alcohol-dependent patients despite having 
normal VFT performance, which may precede behavioral or 
cognitive deterioration with a later onset (12). Other disorders, 
such as anxiety, autism, attention-deficit hyperactivity disorders, 
dementia, and eating disorders, have also been studied using 
NIRS, which revealed intriguing findings that warrants further 
investigation.
Beyond the use of NIRS in studying phenomenological char-
acterization of disorders, it has also been trialed as a treatment 
tool, such as in the use of neurobiofeedback to enhance efficacy 
of mental practice with motor imagery (13). It has also been 
combined with other treatment modalities, such as transcranial 
magnetic stimulation (TMS) (14) and trancranial direct current 
stimulation (15), to monitor treatment effects. With the creative 
use of both neurostimulation and imaging, it opens up new 
opportunities for neurocognitive augmentation and remediation.
With psychiatric disorders being strongly predisposed by 
genetic factors with estimated heritability for schizophrenia, bipo-
lar disorder, and autism being much higher than that of diseases, 
such as breast cancer and Parkinson disease (16), this leads to an 
integrated research method known as imaging genetics, which 
uses neuroimaging and genetics to assess the impact of genetic 
variation on brain structure and function (17). It aims to unravel 
the genes at risk for psychiatric disorders and to characterize the 
neural systems and brain functions implicated as a result of the 
disorders. The ability to quickly assess large numbers of subjects 
with easy set up of apparatus allows optical topography to be used 
in this emerging field. For instance, Takizawa et al. demonstrated 
that the prefrontal NIRS signals was able to detect the impact 
of catechol-O-methyl transferase (COMT) polymorphism in 
patients with schizophrenia, with the Met carriers having greater 
oxygenation increase in VFT than Val/Val individuals (18).
There has also been increasing debate over the potential 
of NIRS in diagnosis of mental illnesses. In 2004, Suto et  al. 
reported unique disorder-specific cerebral oxygenation patterns 
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in depression and schizophrenia as compared to healthy controls 
(19). In 2013, Takizawa et al. in a multisite study further revealed 
frontal hemodynamic patterns in NIRS that were able to accu-
rately distinguish among patients with major depressive disorder, 
schizophrenia, and bipolar disorder using specific algorithms (6). 
In view of such findings, the Japanese Health Ministry in 2014 
approved optical topography as an “advanced medical technol-
ogy” and is an insurance-covered investigation to aid differential 
diagnosis of depressive state (20). While many would concur 
that NIRS does hold potential in the area of assisted diagnosis, 
there are still many areas of considerations such as the need for 
more targeted activation paradigms to delineate the disease-
specific hemodynamic changes, need for validated markers with 
increased diagnostic specificity, the technical and methodical 
difficulties involved in interpreting the data, and medico-legal 
implications. Thus, at its current state, it is improbable to replace 
conventional history taking and neuropsychological assessment 
in the management of psychiatric disorders.
A WinDOW inTO THE MinD–BRAin 
inTERFACE
Optical topography indeed is a welcoming addition to the reper-
toire of brain imaging modalities, and it offers new possibilities 
to relook at the underlying brain mechanisms of our psychiatric 
patients in a more natural setting and with creative combinations 
of various technologies to facilitate the holistic understanding of 
the mind–brain interface. Most psychiatric studies using NIRS 
so far have concentrated on assessing prefrontal activation by 
using VFT, which is the most popular paradigm that is simple to 
administer and able to reliably show differences between patients 
and controls. Nevertheless, it only covers a restricted aspect of 
executive functioning, which would be inadequate in delineating 
and differentiating complex psychiatric disorders. Thus, more 
specific activation paradigms will need to be created to target 
the different groups of psychiatric conditions with their unique 
characteristics, and extending to various cortical areas to enhance 
the detection of etiologically relevant cerebral hemodynamic 
changes that reflect functional alteration. Although optical 
topography currently is still very much a research utility, with 
further development of this technology, it is just a matter of time 
before it becomes a valuable clinical tool and by then, the practice 
of Psychiatry would be revolutionized and demystifying of the 
human mind would become a reality.
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